UPDATE 1-Mylan revenue rises on generic drugs boost, reaffirms outlook
May 03, 2016 at 04:49 AM EDT
May 3 (Reuters) - Drugmaker Mylan NV posted a 17 percent rise in quarterly revenue, helped by higher generic drug sales, and stood by its full-year revenue and adjusted profit guidance.
